论文部分内容阅读
为探讨免疫药物在肾癌切除术后治疗中的作用,对155例患者肾癌患者进行分析,按时间先后将155例分成A、B两组,A组术后单用孕酮,B组术后再加用α-干扰素和白细胞介素-2,通过较长期随访比较,两组早期(Ⅰ~Ⅱ期)肾癌5年生存率无显著性差异,晚期(Ⅲ期以上)肾癌5年生存率有显著性差异(P<0.05)。认为α-干扰素和白细胞介素-2对晚期肾癌有效。
In order to explore the role of immune drugs in the treatment of renal cancer after resection, analysis of 155 patients with renal cell carcinoma, according to the time will have 155 cases were divided into A, B two groups, A group of postoperative single progesterone, B group After the addition of interferon-alpha and interleukin-2, compared with the long-term follow-up, there was no significant difference in the 5-year survival rate between the two groups (stage Ⅰ ~ Ⅱ) The annual survival rate was significantly different (P <0.05). Alpha-interferon and interleukin-2 are considered effective for advanced renal cancer.